Common-Size Income Statement
Paying user area
Try for free
Humana Inc. pages available for free this week:
- Statement of Comprehensive Income
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Selected Financial Data since 2005
- Net Profit Margin since 2005
- Operating Profit Margin since 2005
- Return on Equity (ROE) since 2005
- Price to Operating Profit (P/OP) since 2005
- Price to Book Value (P/BV) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Humana Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Humana Inc., common-size consolidated income statement
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
- Revenue Composition
- Premiums consistently represent the majority of external revenues, showing a slight downward trend from 97.77% in 2019 to 94.84% in 2022, followed by a modest recovery to 96.17% in 2023. Services revenues have increased significantly from 2.23% in 2019 to a peak of 5.16% in 2022, before declining to 3.83% in 2023. Investment income has shown volatility, reaching a high of 1.52% in 2020, declining sharply in 2021, and partially recovering by 2023.
- Cost Structure
- Benefits expenses have fluctuated near the mid-80% range of external revenues, showing a slight improvement in some years but ultimately increasing to -83.94% in 2023, close to the 2019 level. Operating costs exhibit variability without a clear trend, peaking at -13.7% in 2022, then decreasing to -12.52% in 2023. Depreciation and amortization expenses remain relatively stable, generally near -0.7% throughout the analyzed period.
- Operating Expenses and Income
- Total operating expenses account for a substantial portion of external revenues, consistently near -96%. Income from operations fluctuated, increasing from 4.96% in 2019 to a peak of 6.56% in 2020, but then declined to 3.81% by 2023. A notable one-time gain on the sale of Gentiva Hospice was realized in 2022, contributing 0.26% of external revenues.
- Financial Expenses and Other Income
- Interest expense has gradually increased from -0.38% in 2019 to -0.47% in 2023, indicating higher borrowing costs or debt levels. Other income (expense), net, has been inconsistent, showing positive contributions in some years (2019 and 2021) but marginal negative impacts in most recent years.
- Profitability
- Income before income taxes and equity in net earnings declined steadily from 5.37% in 2019 to 3.21% in 2023. The provision for income taxes peaked in 2020 at -1.72%, then stabilized around -0.79% by 2023. Equity in net earnings remained relatively insignificant throughout the period.
- Net Income
- Net income attributable to the company showed a clear downward trend over the five-year period, decreasing from 4.2% of external revenues in 2019 to 2.36% in 2023. This decline reflects pressures on profitability despite relatively stable revenue components and cost management.